Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The adrenergic receptor alpha-2C (ADRA2C) is a G protein-coupled receptor (GPCR) that belongs to the alpha-2 adrenergic receptor family. It regulates neurotransmitter release and mediates catecholamine-induced inhibition of adenylate cyclase. ADRA2C plays roles in cardiovascular regulation and has implications for neuropsychiatric disorders.
Catecholamine-induced inhibition of adenylate cyclase via G proteins, leading to decreased cAMP levels within cells; modulation of neurotransmitter release; vasoconstriction.
11 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adrenoceptor Alpha 2C (ADRA2C).